Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Xanthinol | hsa00010 | Glycolysis / Gluconeogenesis | 4.41E-02 | 4 | P04075, P06733, P04406, P60174 | ALDOA, ENO1, GAPDH, TPI1 | More | | Xanthinol | hsa00040 | Pentose and glucuronate interconversions | 9.59E-03 | 2 | P15121, P14550 | AKR1B1, AKR1A1 | More | | Xanthinol | hsa00051 | Fructose and mannose metabolism | 2.21E-02 | 3 | O14772, P60174, P04075 | FPGT, TPI1, ALDOA | More | | Xanthinol | hsa00280 | Valine, leucine and isoleucine degradation | 4.55E-02 | 2 | P21953, P51648 | BCKDHB, ALDH3A2 | More | | Xanthinol | hsa00310 | Lysine degradation | 5.61E-03 | 2 | Q96KQ7, P51648 | EHMT2, ALDH3A2 | More | | Xanthinol | hsa00533 | Glycosaminoglycan biosynthesis - keratan sulfate | 2.92E-02 | 1 | Q9NY97 | B3GNT2 | More | | Xanthinol | hsa00561 | Glycerolipid metabolism | 7.94E-03 | 3 | P15121, P14550, Q86XP1 | AKR1B1, AKR1A1, DGKH | More | | Xanthinol | hsa01200 | Carbon metabolism | 5.71E-03 | 7 | P04075, P04406, P60174, P06733, O14521, Q9P2R7, Q02252 | ALDOA, GAPDH, TPI1, ENO1, SDHD, SUCLA2, ALDH6A1 | More | | Xanthinol | hsa01210 | 2-Oxocarboxylic acid metabolism | 2.92E-02 | 1 | P50213 | IDH3A | More | | Xanthinol | hsa01230 | Biosynthesis of amino acids | 9.38E-03 | 5 | P60174, P04406, P06733, P04075, Q99707 | TPI1, GAPDH, ENO1, ALDOA, MTR | More | | Xanthinol | hsa03010 | Ribosome | 1.60E-02 | 9 | P30050, P40429, P62906, P62917, Q9H0U6, P36578, P05386, P62249, P23396 | RPL12, RPL13A, RPL10A, RPL8, MRPL18, RPL4, RPLP1, RPS16, RPS3 | More | | Xanthinol | hsa03030 | DNA replication | 1.48E-02 | 3 | P49005, P33993, P15927 | POLD2, MCM7, RPA2 | More | | Xanthinol | hsa04020 | Calcium signaling pathway | 5.81E-04 | 7 | Q96DU7, Q13557, P21860, P05141, P12236, P26678, P63092 | ITPKC, CAMK2D, ERBB3, SLC25A5, SLC25A6, PLN, GNAS | More | | Xanthinol | hsa04022 | cGMP-PKG signaling pathway | 9.36E-03 | 6 | P61586, P26678, Q99941, P18848, P05141, P12236 | RHOA, PLN, CREBL1, ATF4, SLC25A5, SLC25A6 | More | | Xanthinol | hsa04145 | Phagosome | 4.79E-02 | 3 | Q71U36, P27824, P30511 | TUBA1A, CANX, HLA-F | More | | Xanthinol | hsa04151 | PI3K-Akt signaling pathway | 1.36E-02 | 9 | P21860, P27348, O14944, P07900, Q15831, P22105, Q99941, P18848, O95988 | ERBB3, YWHAQ, EREG, HSP90AA1, STK11, TNXB, CREBL1, ATF4, TCL1B | More | | Xanthinol | hsa04261 | Adrenergic signaling in cardiomyocytes | 3.12E-02 | 5 | P63092, Q99941, P18848, P26678, Q13557 | GNAS, CREBL1, ATF4, PLN, CAMK2D | More | | Xanthinol | hsa04360 | Axon guidance | 9.54E-03 | 3 | P20827, P23528, Q06124 | EFNA1, CFL1, PTPN11 | More | | Xanthinol | hsa04371 | Apelin signaling pathway | 6.44E-03 | 4 | P63218, Q14344, Q13485, Q16566 | GNG5, GNA13, SMAD4, CAMK4 | More | | Xanthinol | hsa04612 | Antigen processing and presentation | 4.79E-02 | 3 | P30101, P30511, P27824 | PDIA3, HLA-F, CANX | More | | Xanthinol | hsa04662 | B cell receptor signaling pathway | 1.70E-02 | 3 | P60033, P07948, Q8N149 | CD81, LYN, LILRA2 | More | | Xanthinol | hsa04720 | Long-term potentiation | 4.55E-02 | 2 | Q16566, O15399 | CAMK4, GRIN2D | More | | Xanthinol | hsa04730 | Long-term depression | 1.09E-02 | 2 | Q14344, P07948 | GNA13, LYN | More | | Xanthinol | hsa04911 | Insulin secretion | 4.47E-03 | 4 | P63092, Q99941, P18848, Q13557 | GNAS, CREBL1, ATF4, CAMK2D | More | | Xanthinol | hsa04920 | Adipocytokine signaling pathway | 2.06E-02 | 2 | Q06124, Q9Y478 | PTPN11, PRKAB1 | More | | Xanthinol | hsa04925 | Aldosterone synthesis and secretion | 1.68E-02 | 4 | Q99941, P18848, P63092, Q13557 | CREBL1, ATF4, GNAS, CAMK2D | More | | Xanthinol | hsa04927 | Cortisol synthesis and secretion | 2.40E-02 | 3 | Q99941, P18848, P63092 | CREBL1, ATF4, GNAS | More | | Xanthinol | hsa04928 | Parathyroid hormone synthesis, secretion and action | 2.33E-02 | 4 | P63092, P61586, Q99941, P18848 | GNAS, RHOA, CREBL1, ATF4 | More | | Xanthinol | hsa04934 | Cushing syndrome | 1.37E-03 | 5 | Q99941, P18848, P63092, O15169, Q13557 | CREBL1, ATF4, GNAS, AXIN1, CAMK2D | More | | Xanthinol | hsa05010 | Alzheimer disease | 9.96E-04 | 13 | Q92542, O15239, P05496, O15399, Q9NZJ5, P18848, Q71U36, O15169, P05141, P12236, P21796, P43686, P62195 | NCSTN, NDUFA1, ATP5G1, GRIN2D, EIF2AK3, ATF4, TUBA1A, AXIN1, SLC25A5, SLC25A6, VDAC1, PSMC4, PSMC5 | More | | Xanthinol | hsa05012 | Parkinson disease | 2.88E-03 | 9 | O15239, P05496, P05141, P12236, P63092, P18848, P43686, P62195, Q13557 | NDUFA1, ATP5G1, SLC25A5, SLC25A6, GNAS, ATF4, PSMC4, PSMC5, CAMK2D | More | | Xanthinol | hsa05014 | Amyotrophic lateral sclerosis | 2.41E-03 | 13 | O15399, P20333, O15239, P05496, Q9NZJ5, P18848, Q71U36, P43686, P62195, P21796, P51991, P35658, P43243 | GRIN2D, TNFRSF1B, NDUFA1, ATP5G1, EIF2AK3, ATF4, TUBA1A, PSMC4, PSMC5, VDAC1, HNRPA3, NUP214, MATR3 | More | | Xanthinol | hsa05020 | Prion disease | 3.57E-04 | 13 | P46531, O15239, P05496, O15399, Q9NZJ5, P18848, P05141, P12236, P21796, P43686, P62195, Q71U36, Q99941 | NOTCH1, NDUFA1, ATP5G1, GRIN2D, EIF2AK3, ATF4, SLC25A5, SLC25A6, VDAC1, PSMC4, PSMC5, TUBA1A, CREBL1 | More | | Xanthinol | hsa05022 | Pathways of neurodegeneration - multiple diseases | 1.57E-02 | 10 | O15239, P05496, P18848, P05141, P12236, P20333, O15169, Q13557, P43686, P62195 | NDUFA1, ATP5G1, ATF4, SLC25A5, SLC25A6, TNFRSF1B, AXIN1, CAMK2D, PSMC4, PSMC5 | More | | Xanthinol | hsa05030 | Cocaine addiction | 2.40E-02 | 3 | P63092, Q99941, P18848 | GNAS, CREBL1, ATF4 | More | | Xanthinol | hsa05031 | Amphetamine addiction | 4.47E-03 | 4 | Q13557, P63092, Q99941, P18848 | CAMK2D, GNAS, CREBL1, ATF4 | More | | Xanthinol | hsa05144 | Malaria | 2.60E-02 | 2 | P69905, O60603 | HBA2, TLR2 | More | | Xanthinol | hsa05163 | Human cytomegalovirus infection | 2.77E-02 | 4 | P30511, P63218, Q14344, P30101 | HLA-F, GNG5, GNA13, PDIA3 | More | | Xanthinol | hsa05203 | Viral carcinogenesis | 7.09E-03 | 6 | Q99941, P18848, P27348, Q15283, P61586, P61978 | CREBL1, ATF4, YWHAQ, RASA2, RHOA, HNRPK | More | | Xanthinol | hsa05205 | Proteoglycans in cancer | 4.43E-02 | 3 | P63261, O60603, Q06124 | ACTG1, TLR2, PTPN11 | More | | Xanthinol | hsa05206 | MicroRNAs in cancer | 1.54E-02 | 6 | P21860, P61978, P46531, P63279, P22105, P61586 | ERBB3, HNRPK, NOTCH1, UBE2I, TNXB, RHOA | More | | Xanthinol | hsa05415 | Diabetic cardiomyopathy | 1.92E-02 | 6 | P05141, P12236, O15239, P05496, Q13557, P26678 | SLC25A5, SLC25A6, NDUFA1, ATP5G1, CAMK2D, PLN | More | | |